Literature DB >> 2939076

Stimulation of bovine cardiac sarcoplasmic reticulum Ca2+ pump and blocking of phospholamban phosphorylation and dephosphorylation by a phospholamban monoclonal antibody.

T Suzuki, J H Wang.   

Abstract

A monoclonal antibody, A1, was produced against sodium dodecyl sulfate-polyacrylamide gel electrophoresis purified canine phospholamban and isolated from mouse ascites by chromatography on a hydroxylapatite column. Western immunoblotting experiments showed that the antibody was specific for phospholamban and cross-reacted with the protein from a bovine source. Incubation of bovine cardiac sarcoplasmic reticulum (SR) vesicles with the antibody resulted in a marked increase in the ATP-dependent Ca2+ pump activity which was slightly higher than that brought about by cyclic AMP-dependent protein kinase. This observation provides direct proof for the involvement of phospholamban as a SR Ca2+ pump regulatory protein. In addition to stimulating the Ca2+ pump activity, antibody A1 was capable of blocking the phosphorylation of phospholamban by cyclic AMP-dependent protein kinase and by an endogenous SR Ca2+/calmodulin-dependent protein kinase. It was also capable of blocking the dephosphorylation of phosphorylated phospholamban by an endogenous SR protein phosphatase. From these observations, it may be suggested that the antigenic site of A1 antibody is proximal to the phosphorylation sites of phospholamban.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2939076

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Computational design of a water-soluble analog of phospholamban.

Authors:  Avram M Slovic; Christopher M Summa; James D Lear; William F DeGrado
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

2.  Sarcoplasmic reticulum calcium load regulates rat arterial smooth muscle calcium sparks and transient K(Ca) currents.

Authors:  Serguei Y Cheranov; Jonathan H Jaggar
Journal:  J Physiol       Date:  2002-10-01       Impact factor: 5.182

3.  Functional difference between SERCA2a and SERCA2b Ca2+ pumps and their modulation by phospholamban.

Authors:  H Verboomen; F Wuytack; H De Smedt; B Himpens; R Casteels
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

4.  Phospholamban phosphorylation increases the passive calcium leak from cardiac sarcoplasmic reticulum.

Authors:  Roozbeh Aschar-Sobbi; Teresa L Emmett; Gary J Kargacin; Margaret E Kargacin
Journal:  Pflugers Arch       Date:  2012-07-07       Impact factor: 3.657

5.  Anti-phospholamban and protein kinase A alter the Ca2+ sensitivity and maximum velocity of Ca2+ uptake by the cardiac sarcoplasmic reticulum.

Authors:  M E Kargacin; Z Ali; G Kargacin
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

6.  Phosphorylation of cardiac junctional and free sarcoplasmic reticulum by PKC alpha, PKC beta, PKA and the Ca2+/calmodulin-dependent protein kinase.

Authors:  B G Allen; S Katz
Journal:  Mol Cell Biochem       Date:  1996-02-23       Impact factor: 3.396

7.  Assessment of intra-SR free [Ca] and buffering in rat heart.

Authors:  T R Shannon; D M Bers
Journal:  Biophys J       Date:  1997-09       Impact factor: 4.033

8.  Phosphorylation of phospholamban in ischemia-reperfusion injury: Functional role of Thr(17) residue.

Authors:  A Mattiazzi; C Mundiña-Weilenmann; L Vittone; M Said
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

9.  The phosphoprotein that regulates platelet Ca2+ transport is located on the plasma membrane, controls membrane-associated Ca2(+)-ATPase and is not glycoprotein Ib beta-subunit.

Authors:  A Darnanville; R Bredoux; K J Clemetson; N Kieffer; N Bourdeau; S Levy-Toledano; J P Caen; J Enouf
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

10.  Translation of Ser16 and Thr17 phosphorylation of phospholamban into Ca 2+-pump stimulation.

Authors:  W A Jackson; J Colyer
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.